Digestive health remains one of the most established probiotic categories, with growing awareness of the microbiome’s role in overall wellbeing. Probi develops clinically documented solutions supporting gastrointestinal health and microbiome balance.

Demand for immune-support products continues to grow across supplements, food and beverage categories. Probi’s clinically studied strains help brands develop credible immune health solutions backed by science.

Women’s health is becoming an increasingly targeted area for probiotic innovation. Probi offers clinically validated solutions supporting women through key life stages, from from reproductive years to menopause.

Interest in the gut–brain axis is creating new opportunities in mood, stress, sleep and cognitive wellness. Probi develops science-backed psychobiotic solutions for this emerging category.

Growing interest in weight management, cardiovascular health and inflammation is putting metabolic health firmly in focus. Probi’s clinically documented strains help brands innovate in this evolving space.

As interest in the oral microbiome grows, Probi supports product development with clinically researched BLIS K12™ and BLIS M18™ strains for oral, ENT (ear, nose, throat) health.

Healthy aging continues to drive demand for proactive wellness solutions. Probi develops biotic concepts supporting digestive, immune, cognitive and bone health for later in life.

Demand for evidence-based children’s health products continues to rise. The team at Probi develops clinically studied probiotic solutions designed for younger consumers and family-focused brands.

Sports nutrition is expanding beyond performance into recovery and gut health support. Probi develops science-backed probiotic solutions for active nutrition applications.

Probi is exploring the potential of probiotics to support health and wellbeing in pets. Our science-driven approach focuses on developing targeted, evidence-based solutions for the growing pet health market.